Literature DB >> 7538131

Structure of the O-glycans in GlyCAM-1, an endothelial-derived ligand for L-selectin.

S Hemmerich1, H Leffler, S D Rosen.   

Abstract

L-selectin, the leukocyte selectin, mediates the carbohydrate-dependent attachment of circulating leukocytes to endothelium, preceding emigration into tissues. It functions in inflammatory leukocyte trafficking and in lymphocyte homing to lymph nodes. From previous work, the binding of L-selectin to endothelial-associated glycoprotein ligands, GlyCAM-1 and CD34, requires oligosaccharide sialylation, sulfation, and probably fucosylation. We have recently identified a major capping group in GlyCAM-1 as 6' sulfated sialyl Lewis x, a novel structure which potentially satisfies all of these requirements. In the present study, we define the complete structure of beta-eliminated chains of GlyCAM-1 using metabolic radiolabeling, plant lectin binding, and glycosidase digestions in conjunction with high pH anion-exchange chromatography. The majority of the O-glycans in GlyCAM-1 contain the T-antigen, i.e. Gal beta 1-->3GalNAc, which is incorporated into the core-2 structure, i.e. Gal beta 1-->3[GlcNAc beta 1-->6]GalNAc or larger core structures with additional GlcNAc residues. The structures of two O-glycans, based on core-2, were determined to be: [sequence: see text] The implications of these structures and more complex O-glycans for binding by L-selectin are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538131     DOI: 10.1074/jbc.270.20.12035

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Endothelial ligands for L-selectin: from lymphocyte recirculation to allograft rejection.

Authors:  S D Rosen
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

2.  Cell-free rolling mediated by L-selectin and sialyl Lewis(x) reveals the shear threshold effect.

Authors:  A W Greenberg; D K Brunk; D A Hammer
Journal:  Biophys J       Date:  2000-11       Impact factor: 4.033

3.  A small-molecule switch for Golgi sulfotransferases.

Authors:  Christopher L de Graffenried; Scott T Laughlin; Jennifer J Kohler; Carolyn R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-17       Impact factor: 11.205

4.  Profile of Carolyn Bertozzi. Interview by Tinsley Davis.

Authors:  Carolyn Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

5.  Human L-selectin preferentially binds synthetic glycosulfopeptides modeled after endoglycan and containing tyrosine sulfate residues and sialyl Lewis x in core 2 O-glycans.

Authors:  Anne Leppänen; Ville Parviainen; Elina Ahola-Iivarinen; Nisse Kalkkinen; Richard D Cummings
Journal:  Glycobiology       Date:  2010-05-27       Impact factor: 4.313

Review 6.  Two distinct lymphocyte homing systems involved in the pathogenesis of chronic inflammatory gastrointestinal diseases.

Authors:  Motohiro Kobayashi; Hitomi Hoshino; Kenichi Suzawa; Yasuhiro Sakai; Jun Nakayama; Minoru Fukuda
Journal:  Semin Immunopathol       Date:  2012-05-10       Impact factor: 9.623

Review 7.  Selectin ligands: will the real ones please stand up?

Authors:  A Varki
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

8.  KSGal6ST generates galactose-6-O-sulfate in high endothelial venules but does not contribute to L-selectin-dependent lymphocyte homing.

Authors:  Michael L Patnode; Shin-Yi Yu; Chu-Wen Cheng; Ming-Yi Ho; Lotten Tegesjö; Keiichiro Sakuma; Kenji Uchimura; Kay-Hooi Khoo; Reiji Kannagi; Steven D Rosen
Journal:  Glycobiology       Date:  2012-12-18       Impact factor: 4.313

Review 9.  Carbohydrate-dependent defense mechanisms against Helicobacter pylori infection.

Authors:  Motohiro Kobayashi; Heeseob Lee; Jun Nakayama; Minoru Fukuda
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

10.  Anti-oligosaccharide antibodies as tools for studying sulfated sialoglycoconjugate ligands for siglecs and selectins.

Authors:  Reiji Kannagi; Katsuyuki Ohmori; Naoko Kimura
Journal:  Glycoconj J       Date:  2009-11       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.